These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29184682)

  • 1. Survival differences among patients with hepatocellular carcinoma based on the stage of disease and therapy received: pre and post sorafenib era.
    Shah C; Mramba LK; Bishnoi R; Bejjanki H; Chhatrala HS; Chandana SR
    J Gastrointest Oncol; 2017 Oct; 8(5):789-798. PubMed ID: 29184682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival trends of metastatic small intestinal neuroendocrine tumor: a population-based analysis of SEER database.
    Shah CP; Mramba LK; Bishnoi R; Unnikrishnan A; Duff JM; Chandana SR
    J Gastrointest Oncol; 2019 Oct; 10(5):869-877. PubMed ID: 31602324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival and cost-effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: An analysis of the SEER-Medicare database.
    Parikh ND; Marshall VD; Singal AG; Nathan H; Lok AS; Balkrishnan R; Shahinian V
    Hepatology; 2017 Jan; 65(1):122-133. PubMed ID: 27770556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
    Ding J; Wen Z
    BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis.
    Piñero F; Marciano S; Fernández N; Silva J; Anders M; Zerega A; Ridruejo E; Romero G; Ameigeiras B; D'Amico C; Gaite L; Bermúdez C; Reggiardo V; Colombato L; Gadano A; Silva M
    World J Gastroenterol; 2019 Jul; 25(27):3607-3618. PubMed ID: 31367160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of VEGF and HIF-1 α in Hepatocellular Carcinoma Patients Receiving Sorafenib Versus Metformin Sorafenib Combination.
    El Shorbagy S; abuTaleb F; Labib HA; Ebian H; Harb OA; Mohammed MS; Rashied HA; Elbana KA; Haggag R
    J Gastrointest Cancer; 2021 Mar; 52(1):269-279. PubMed ID: 32212089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma.
    Sanoff HK; Chang Y; Lund JL; O'Neil BH; Dusetzina SB
    Oncologist; 2016 Sep; 21(9):1113-20. PubMed ID: 27185615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barcelona clinic liver cancer-stage C hepatocellular carcinoma: A novel approach to subclassification and treatment.
    Jun CH; Yoon JH; Cho E; Shin SS; Cho SB; Kim HJ; Park CH; Kim HS; Choi SK; Rew JS
    Medicine (Baltimore); 2017 Apr; 96(17):e6745. PubMed ID: 28445298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial.
    Gandhi M; Choo SP; Thng CH; Tan SB; Low AS; Cheow PC; Goh AS; Tay KH; Lo RH; Goh BK; Wong JS; Ng DC; Soo KC; Liew WM; Chow PK;
    BMC Cancer; 2016 Nov; 16(1):856. PubMed ID: 27821083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival characteristics of fibrolamellar hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results database study.
    Sempokuya T; Forlemu A; Azawi M; Silangcruz K; Khoury N; Ma J; Wong LL
    World J Clin Oncol; 2022 May; 13(5):352-365. PubMed ID: 35662983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical therapy for early hepatocellular carcinoma in the modern era: a 10-year SEER-medicare analysis.
    Nathan H; Hyder O; Mayo SC; Hirose K; Wolfgang CL; Choti MA; Pawlik TM
    Ann Surg; 2013 Dec; 258(6):1022-7. PubMed ID: 23299519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioembolisation with yttrium‒90 microspheres versus sorafenib for treatment of advanced hepatocellular carcinoma (SARAH): study protocol for a randomised controlled trial.
    Vilgrain V; Abdel-Rehim M; Sibert A; Ronot M; Lebtahi R; Castéra L; Chatellier G;
    Trials; 2014 Dec; 15():474. PubMed ID: 25472660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced hepatocellular carcinoma: A regional cancer center experience of 48 cases.
    Lokesh KN; Chaudhuri T; Lakshmaiah KC; Babu KG; Dasappa L; Jacob LA; Suresh Babu MC; Rudresha AH; Rajeev LK
    Indian J Cancer; 2017; 54(3):526-529. PubMed ID: 29798951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatectomy combined with sorafenib in patients with intermediate-advanced hepatocellullar carcinoma.
    Zhu H; Ye B; Qiao Z; Zeng L; Li Q
    J BUON; 2019; 24(4):1382-1389. PubMed ID: 31646781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis
.
    Huang Y; Chen B; Liu N; Li N; Dao H; Chen W; Yang J
    Int J Clin Pharmacol Ther; 2017 Jun; 55(6):498-508. PubMed ID: 28157070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib.
    Pinter M; Sieghart W; Hucke F; Graziadei I; Vogel W; Maieron A; Königsberg R; Weissmann A; Kornek G; Matejka J; Stauber R; Buder R; Grünberger B; Schöniger-Hekele M; Müller C; Peck-Radosavljevic M
    Aliment Pharmacol Ther; 2011 Oct; 34(8):949-59. PubMed ID: 21883324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.
    Peng Z; Chen S; Xiao H; Wang Y; Li J; Mei J; Chen Z; Zhou Q; Feng S; Chen M; Qian G; Peng S; Kuang M
    Radiology; 2019 Jul; 292(1):237-247. PubMed ID: 31135299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoption of Sorafenib for the Treatment of Advanced-Stage Hepatocellular Carcinoma in Oncology Practices in the United States.
    Parsons HM; Chu Q; Karlitz JJ; Stevens JL; Harlan LC
    Liver Cancer; 2017 Jun; 6(3):216-226. PubMed ID: 29234628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the neutrophil-to-lymphocyte ratio predict the prognosis of patients with advanced hepatocellular carcinoma treated with sorafenib.
    Hong YM; Yoon KT; Hwang TH; Heo J; Woo HY; Cho M
    Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1250-1255. PubMed ID: 30925530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma.
    Kelley RK; Mollon P; Blanc JF; Daniele B; Yau T; Cheng AL; Valcheva V; Marteau F; Guerra I; Abou-Alfa GK
    Adv Ther; 2020 Jun; 37(6):2678-2695. PubMed ID: 32424805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.